Underreporting and Triggering Factors for Reporting ADRs of Two Ophthalmic Drugs: A Comparison between Spontaneous Reports and Active Pharmacovigilance Databases.

Autor: Contreras-Salinas H; Pharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan 45010, Jalisco, Mexico., Baiza-Durán LM; Pharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan 45010, Jalisco, Mexico., Bautista-Castro MA; Pharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan 45010, Jalisco, Mexico., Alonso-Rodríguez DR; Pharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan 45010, Jalisco, Mexico., Rodríguez-Herrera LY; Pharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan 45010, Jalisco, Mexico.

Publikováno v: Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2022 Oct 31; Vol. 10 (11). Date of Electronic Publication: 2022 Oct 31.